Login to Your Account



Advicenne extends runway for pediatric meds with $17.3M

By Nuala Moran
Staff Writer

Tuesday, March 21, 2017

LONDON – Pediatric medicines specialist Advicenne SA closed a €16 million round, providing the means to complete phase III development of ADV7103 for treating renal tubulopathy.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription